| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.47 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.31 | 0.04 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.28 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.27 | 0.04 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.26 | 0.1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.19 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |